KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $81,942 | -18.9% | 7,745 | +23.0% | 0.00% | – |
| Q1 2022 | $101,000 | +65.6% | 6,296 | +93.0% | 0.00% | – |
| Q3 2021 | $61,000 | +8.9% | 3,263 | +21.9% | 0.00% | – |
| Q2 2021 | $56,000 | -26.3% | 2,676 | 0.0% | 0.00% | – |
| Q1 2021 | $76,000 | -78.6% | 2,676 | -75.3% | 0.00% | -100.0% |
| Q4 2020 | $355,000 | +1167.9% | 10,855 | +1069.7% | 0.00% | – |
| Q3 2020 | $28,000 | -44.0% | 928 | -70.0% | 0.00% | – |
| Q2 2020 | $50,000 | +177.8% | 3,091 | +72.2% | 0.00% | – |
| Q1 2020 | $18,000 | -48.6% | 1,795 | -29.7% | 0.00% | – |
| Q4 2019 | $35,000 | +218.2% | 2,552 | +235.3% | 0.00% | – |
| Q4 2018 | $11,000 | -15.4% | 761 | +0.5% | 0.00% | – |
| Q3 2018 | $13,000 | +18.2% | 757 | +24.7% | 0.00% | – |
| Q2 2018 | $11,000 | +10.0% | 607 | +9.8% | 0.00% | – |
| Q1 2018 | $10,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |